title: Calcitonin gene-related peptide and adrenomedullin release in humans: effects of exercise and hypoxia.
abstract: Calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) are potent vasorelaxant peptides. This study examined exercise-induced changes in CGRP and AM levels in 12 healthy sea level natives at sea level (SL) and subsequently after 24 h (HA1) and 5 days (HA5) in high altitude hypoxia (4559 m). Plasma values of CGRP, AM, calcitonin, noradrenaline, adrenaline, lactate and heart rate were measured at rest and during maximal exercise (W(max)). On each study day, the dopamine D(2)-receptor antagonist, domperidone (30 mg; n=6), or no medication (n=6) was given 1 h before exercise. W(max) at SL, HA1 and HA5 increased CGRP and AM along with heart rate, lactate and catecholamines, whereas, calcitonin remained unchanged. The maximal CGRP levels at W(max) were significantly decreased at HA1 (74.3+/-6.1 pmol/l; p=0.002) and HA5 (69.6+/-6.0 pmol/l; p<0.001) compared to maximal CGRP at SL (85.1+/-4.9 pmol/l). A similar pattern was observed for lactate and the relation between CGRP and lactate release showed a close linear correlation (r(2)=0.63, P<0.0001). Domperidone produced a marked increase in noradrenaline at W(max), but had no affect on CGRP or AM. In conclusion, CGRP release during hypoxic exercise does not respond to domperidone-induced changes in circulating levels of noradrenaline, rather the release may be directly related to the production of lactate.
authors.affiliation: Department of Clinical Physiology and Nuclear Medicine, University Hospital of Herlev, Herlev, Denmark. Philip@Hasbak.dk
authors.forename: Philip
authors.initials: P
authors.lastname: Hasbak
authors.forename: Carsten
authors.initials: C
authors.lastname: Lundby
authors.forename: Niels Vidiendal
authors.initials: NV
authors.lastname: Olsen
authors.forename: Søren
authors.initials: S
authors.lastname: Schifter
authors.forename: Inge-Lis
authors.initials: IL
authors.lastname: Kanstrup
mesh_terms: D053607:Adrenomedullin; D000328:Adult; D000531:Altitude; D000532:Altitude Sickness / Q000503:physiopathology; D002116:Calcitonin / Q000097:blood; D015740:Calcitonin Gene-Related Peptide / Q000097:blood / Q000378:metabolism*; D004294:Domperidone / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D004837:Epinephrine / Q000097:blood; D015444:Exercise / Q000502:physiology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007773:Lactates / Q000097:blood; D008297:Male; D009638:Norepinephrine / Q000097:blood; D010455:Peptides / Q000097:blood / Q000378:metabolism*; D012016:Reference Values; D014664:Vasodilation
chemical_list: D018492:Dopamine Antagonists; D007773:Lactates; D010455:Peptides; D053607:Adrenomedullin; D004294:Domperidone; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide; D009638:Norepinephrine; D004837:Epinephrine